fashion -WSS

fashion

author：knowledge 2025-09-06 08:24:51 - browse：1

Illustration of researchers working among oversized pill bottles, lab equipment, and medicine for story about the development of obesity medications – health and pharma coverage from STAT — Molly Ferguson for STAT

The exploding popularity of drugs like Wegovy and Mounjaro has propelled dozens of companies to develop their own obesity treatments, with most of them trying to emulate the same approach as the blockbuster products.

Nearly 70 obesity treatments are in development, and about two-thirds use a similar mechanism as Wegovy and Mounjaro, according to the STAT Obesity Drug Tracker, a new database compiled by STAT. There are also a minority of companies pursuing entirely different approaches, hoping that they will stand out among the field.

The tracker, which will be updated with significant developments each quarter, gives a sense of what new mechanisms could hit the market, how they would be delivered, and which companies are running the most trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Juul spent big to court Black leaders to promote its e

WSS

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Cybersecurity threat forces Lurie Children's to take systems offline

Ransomware attacks on hospitals: Study outlines patient impact

Some dementia cases could be undiagnosed liver disease

FDA's Woodcock to retire early next year

Morphosys mixed study results for blood cancer drug

leisure time

fashion

entertainment

The high cost of giving birth even with insurance

CRISPR pioneers react to Casgevy, first gene

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Supreme Court strikes down use of affirmative action

Biden administration opens offers in Medicare drug price negotiations

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Gain of function research would be limited under House proposal

After affirmative action ruling, medical educators look to 'holistic review'

Anthos stroke drug appears safer than common blood thinner

hotspot

Medicare drug price negotiation’s day in court

Wegovy, Zepbound and weight loss drugs that preserve muscle

Covid misinformation case heads to Supreme Court

CRISPR pioneers react to Casgevy, first gene

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Vertex non

explore

focus

focus

Wikipedia